0001567619-22-018275.txt : 20221005
0001567619-22-018275.hdr.sgml : 20221005
20221005164057
ACCESSION NUMBER: 0001567619-22-018275
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220930
FILED AS OF DATE: 20221005
DATE AS OF CHANGE: 20221005
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stanker James H
CENTRAL INDEX KEY: 0001681718
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39531
FILM NUMBER: 221296157
MAIL ADDRESS:
STREET 1: 9008 SHADYBROOK DRIVE
CITY: FREDERICK
STATE: MD
ZIP: 21701
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Processa Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001533743
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 451539785
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7380 COCA COLA DRIVE
STREET 2: SUITE 106
CITY: HANOVER
STATE: MD
ZIP: 21076
BUSINESS PHONE: 443-776-3133
MAIL ADDRESS:
STREET 1: 7380 COCA COLA DRIVE
STREET 2: SUITE 106
CITY: HANOVER
STATE: MD
ZIP: 21076
FORMER COMPANY:
FORMER CONFORMED NAME: Heatwurx, Inc.
DATE OF NAME CHANGE: 20111028
4/A
1
doc1.xml
FORM 4/A
X0306
4/A
2022-09-30
2022-10-03
0
0001533743
Processa Pharmaceuticals, Inc.
PCSA
0001681718
Stanker James H
C/O PROCESSA PHARMACEUTICALS, INC.
7380 COCA COLA DRIVE, SUITE 106
HANOVER
MD
21076
0
1
0
0
Chief Financial Officer
Restricted Stock Units
0
2022-09-30
4
A
0
12950
0
D
Common Stock
12950
339663
D
Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death.
Previous filing inadvertently underreported derivative securities beneficially owned by the reporting person.
/s/ James H. Stanker by Michael B. Kirwan, as Attorney-in-Fact
2022-10-05